Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
What Doximity (NYSE: DOCS) CFO resignation means for governance, capital allocation, and investor confidence
Read More Pharma Industry News Five Prime Therapeutics and Zai Lab start Phase 3 study of bemarituzumab for advanced gastric cancer California-based Five Prime Therapeutics and Chinese biopharma Zai Lab have initiated a pivotal Phase 3 trial of bemarituzumab… bypharmanewsdailyOctober 1, 2018
